REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,783,919 | -60.5% | 242,713 | -12.9% | 0.02% | -55.3% |
Q2 2023 | $7,054,074 | +10.9% | 278,707 | +41.1% | 0.05% | +20.5% |
Q1 2023 | $6,361,024 | +21.8% | 197,486 | -30.2% | 0.04% | +30.0% |
Q4 2022 | $5,220,986 | +81.3% | 282,827 | +165.2% | 0.03% | +87.5% |
Q3 2022 | $2,879,000 | -15.0% | 106,628 | -56.5% | 0.02% | -23.8% |
Q2 2022 | $3,389,000 | +640.0% | 245,212 | +943.2% | 0.02% | +425.0% |
Q1 2022 | $458,000 | -49.4% | 23,505 | -57.7% | 0.00% | -55.6% |
Q4 2021 | $906,000 | +63.5% | 55,506 | +179.0% | 0.01% | +28.6% |
Q3 2021 | $554,000 | -46.1% | 19,898 | -42.7% | 0.01% | -41.7% |
Q2 2021 | $1,028,000 | +378.1% | 34,698 | +351.2% | 0.01% | +300.0% |
Q1 2021 | $215,000 | -74.9% | 7,690 | -77.4% | 0.00% | -76.9% |
Q3 2020 | $856,000 | -46.7% | 34,052 | -68.6% | 0.01% | -69.8% |
Q1 2020 | $1,605,000 | +114.6% | 108,435 | +135.3% | 0.04% | +207.1% |
Q4 2019 | $748,000 | +60.2% | 46,085 | +28.1% | 0.01% | +55.6% |
Q2 2019 | $467,000 | -16.6% | 35,982 | +1.3% | 0.01% | -50.0% |
Q1 2019 | $560,000 | +132.4% | 35,511 | +303.8% | 0.02% | +50.0% |
Q2 2018 | $241,000 | +27.5% | 8,795 | +43.2% | 0.01% | +9.1% |
Q1 2018 | $189,000 | – | 6,141 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |